Browsing Tag
Opella
2 posts
Sanofi to acquire Vigil Neuroscience for $470m to advance TREM2-targeting Alzheimer’s therapy
Sanofi to acquire Vigil Neuroscience for $470M, aiming to add VG-3927, a TREM2-based Alzheimer’s drug, to its neurology pipeline.
Sanofi enters exclusive talks with CD&R over $17bn Opella deal
Sanofi has confirmed its exclusive negotiations with Clayton, Dubilier & Rice (CD&R) for the sale of a 50%…